Answers are grounded in this paper and cite their sources.
Preclinical investigation uncovers TARBP2-driven progression in renal cell carcinoma, highlighting its influence on tumor growth and immune modulation.
Study on the molecular mechanisms underlying the role of TARBP2 in renal cell carcinoma progression, with an emphasis on tumor growth and immune modulation, and its potential clinical significance.
No takes yet. Share an insight, caveat, or question.
陈泯宇(Minyu Chen) (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: